Anthony Davies considers the possibility of a new CMC norm in this BPI article

February 14, 2020
Categories
CEO Anthony Davies sitting at head of conference table, gesturing expansively and smiling

In this Feb 2020 bioprocessintl.com article (click here), Dan Stanton talks to Dark Horse CEO Anthony Davies about what pattern Catalent's $315M acquisition of Masthercell might be foreshadowing.

Related Posts

Join the Quarter Horse Newsletter

We’ll send you a quarterly newsletter all things DHC!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.